Anti-inflammatory strategies for the treatment of sepsis (Q35093632)

6 August 2017

1 reference

title

Anti-inflammatory strategies for the treatment of sepsis (English)

1 reference

6 August 2017

0 references

2

Peter A Ward

1 reference

6 August 2017

Niels C Riedemann

1

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

Expert Opinion on Biological Therapy

6 August 2017

published in

1 reference

6 August 2017

volume

3

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

339-350

1 reference

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Adjunctive therapy in sepsis: a critical analysis of the clinical trial programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Protection against endotoxic shock by bactericidal/permeability-increasing protein in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Detection of circulating tumor necrosis factor after endotoxin administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Shock and tissue injury induced by recombinant human cachectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

A multi-centre, double-blind, placebo-controlled study of liposomal prostaglandin E1 (TLC C-53) in patients with acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

The Effects of Intravenous Antioxidants in Patients With Septic Shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Roles of nitric oxide in surgical infection and sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

A new approach in the treatment of hypotension in human septic shock by NG-monomethyl-L-arginine, an inhibitor of the nitric oxide synthetase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Methylene blue reverses endotoxin-induced hypotension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Methylene blue increases myocardial function in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Methylene blue administration in septic shock: a clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Pyridoxalated hemoglobin polyoxyethylene: a nitric oxide scavenger with antioxidant activity for the treatment of nitric oxide-induced shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Comparison of the haemodynamic effects of nitric oxide synthase inhibition and nitric oxide scavenging in endotoxaemic sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Proteolytic inactivation of plasma C1- inhibitor in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Filgrastim in patients with pneumonia and severe sepsis or septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Clinical trials of immunomodulatory therapies in severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Administration of an antibody to E-selectin in patients with septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and polymicrobial intra-abdominal sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Antithrombin III in animal models of sepsis and organ failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

New and emerging therapies for sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Activation of endothelial cell protease activated receptor 1 by the protein C pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Risks and benefits of activated protein C treatment for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

HMG-1 as a late mediator of endotoxin lethality in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Protective effects of C5a blockade in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Increased C5a receptor expression in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Prevention of lymphocyte cell death in sepsis improves survival in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Apoptosis in sepsis: a new target for therapeutic exploration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Liposomal prostaglandin E sub 1 in acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

Effects of N-acetylcysteine on tissue oxygenation in patients with multiple organ failure and evidence of tissue hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.2.339

21 January 2018

Identifiers

DOI

10.1517/14712598.3.2.339

1 reference

6 August 2017

1 reference